4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Meryem Bektas, David S. Rubenstein. The role of intracellular protein O-glycosylation in cell adhesion and disease[J]. The Journal of Biomedical Research, 2011, 25(4): 227-236. DOI: 10.1016/S1674-8301(11)60031-6
Citation: Meryem Bektas, David S. Rubenstein. The role of intracellular protein O-glycosylation in cell adhesion and disease[J]. The Journal of Biomedical Research, 2011, 25(4): 227-236. DOI: 10.1016/S1674-8301(11)60031-6

The role of intracellular protein O-glycosylation in cell adhesion and disease

Funds: 

This work was supported by NIH RO1 (No. AI49427) to Dr David S. Rubenstein.

More Information
  • Post-translational protein modification, including phosphorylation, is generally quick and reversible, facilitat-ing rapid biologic adjustments to altered cellular physiologic demands. In addition to protein phosphorylation, other post-translational modifications have been identified. Intracellular protein O-glycosylation, the addition of the simple sugar O-linked N-acetylglucosamine (O-GlcNAc) to serine/threonine residues, is a relatively recently identified post-translational modification that has added to the complexity by which protein function is regulated. Two intracellular enzymes, O-GlcNAc transferase and O-GlcNAcase, catalyze the addition and removal, respec-tively, of O-GlcNAc to serine and threonine side-chain hydroxyl groups. Numerous proteins, including enzymes, transcription factors, receptors and structural proteins have been shown to be modified by intracellular O-glyco-sylation. In this review, the mechanism and relevance of O-GlcNAc protein modification are discussed in the con-text of cell adhesion and several representative diseases.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Dandan Zheng, Xiya Zhang, Jia Xu, Shuwen Chen, Bin Wang, Xiaoqin Yuan. LncRNA LINC01503 promotes angiogenesis in colorectal cancer by regulating VEGFA expression via miR-342-3p and HSP60 binding[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240190
    [3]Liming Gou, Gang Yang, Sujuan Ma, Tong Ding, Luan Sun, Fang Liu, Jin Huang, Wei Gao. Galectin-14 promotes hepatocellular carcinoma tumor growth via enhancing heparan sulfate proteoglycan modification[J]. The Journal of Biomedical Research, 2023, 37(6): 418-430. DOI: 10.7555/JBR.37.20230085
    [4]Xiaochen Huang, Jiaojiao Guo, Tao Li, Lizhou Jia, Xiaojun Tang, Jin Zhu, Qi Tang, Zhenqing Feng. c-Met-targeted chimeric antigen receptor T cells inhibit hepatocellular carcinoma cells in vitro and in vivo[J]. The Journal of Biomedical Research, 2022, 36(1): 10-21. DOI: 10.7555/JBR.35.20200207
    [5]Henry Liu, Lisa Sangkum, Geoffrey Liu, Michael Green, Marilyn Li, Alan Kaye. Effects of epinephrine on angiogenesis-related gene expressions in cultured rat cardiomyocytes[J]. The Journal of Biomedical Research, 2016, 30(5): 380-385. DOI: 10.7555/JBR.30.20160024
    [6]Yun Pan, Chongqi Sun, Mingde Huang, Yao Liu, Fuzhen Qi, Li Liu, Juan Wen, Jibin Liu, Kaipeng Xie, Hongxia Ma, Zhibin Hu, Hongbing Shen. A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma[J]. The Journal of Biomedical Research, 2014, 28(3): 194-200. DOI: 10.7555/JBR.28.20140052
    [7]Xiaojian Ni, Yingchun Zhao, Jingjing Ma, Tiansong Xia, Xiaoan Liu, Qiang Ding, Xiaoming Zha, Shui Wang. Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients[J]. The Journal of Biomedical Research, 2013, 27(6): 478-485. DOI: 10.7555/JBR.27.20130021
    [8]Zhengshan Wu, Jianjie Qin, Liyong Pu. Omega-3 fatty acid improves the clinical outcome of hepatectomized patients with hepatitis B virus (HBV)-associated hepatocellular carcinoma[J]. The Journal of Biomedical Research, 2012, 26(6): 395-399. DOI: 10.7555/JBR.26.20120058
    [9]Jing Yu, Qi Li, Qing Xu, Lingzhi Liu, Binghua Jiang. MiR-148a inhibits angiogenesis by targeting ERBB3[J]. The Journal of Biomedical Research, 2011, 25(3): 170-177. DOI: 10.1016/S1674-8301(11)60022-5
    [10]Chen Tao, Li Dan, Fuya ling, Gongzi Peng. In vivo and in vitro effects of QHF combined with chemotherapy on hepatocellular carcinoma[J]. The Journal of Biomedical Research, 2010, 24(2): 161-168.

Catalog

    Article Metrics

    Article views (3699) PDF downloads (1337) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return